You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 132 No. 2, August 1973 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (14)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Fibrinolytic Split Products

A Clinicopathological Correlative Study in Adults With Lupus Glomerulonephritis and Various Renal Diseases

Robert E. Bond, MD; James V. Donadio, Jr., MD; Keith E. Holley, MD; E. J. Walter Bowie, BM, BCh

Arch Intern Med. 1973;132(2):182-187.


Abstract

Fibrinolytic split product (FSP) levels were correlated with renal biopsy results in 25 adults with lupus glomerulonephritis and 23 adults with other renal diseases. The FSP levels were elevated in 42 of the 48 patients. Other coagulation studies showed increased plasma fibrinogen levels in 29 of 33 patients, positive ethanol gelation reactions, and prolonged prothrombin, thrombin, or plasma clot times. All platelet counts were normal or slightly elevated. In glomerular capillaries of lupus nephritis patients, elevated FSP levels correlated best with fibrinoid presence, and, to a lesser degree, with fibrin. There were no relationships between FSP levels and glomerular lesions in patients with other renal diseases. Although there was reliable clinical and pathologic evidence for intravascular coagulation in these renal disease patients, the pathogenetic role of intravascular coagulation in destructive and progressive renal lesions in man remains unknown.



Author Affiliations

Rochester, Minn

From the Mayo Clinic and the Mayo Foundation, Rochester, Minn.


Footnotes

Received for publication March 13, 1972; accepted July 7.

Reprint requests to Section of Publications, Mayo Clinic, Rochester, Minn 55901.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Thrombophlebitis in Systemic Lupus Erythematosus
Peck et al.
JAMA 1978;240:1728-1730.
ABSTRACT  

The Spectrum of Vitamin K Deficiency
Ansell et al.
JAMA 1977;238:40-42.
ABSTRACT  

Renal Vein Thrombosis, Nephrotic Syndrome, and Systemic Lupus Erythematosus: An Association in Four Cases
APPEL et al.
ANN INTERN MED 1976;85:310-317.
ABSTRACT  

Systemic Lupus Erythematosus: Contrasts and Comparisons
DECKER et al.
ANN INTERN MED 1975;82:391-404.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1973 American Medical Association. All Rights Reserved.